TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth

X Gao1, D Pan

  • 1Department of Physiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9040, USA.

Genes & Development
|June 8, 2001
PubMed

Insights

Tuberous sclerosis genes TSC1 and TSC2 regulate cell growth by forming a complex. These genes also act as novel negative regulators of insulin signaling, impacting cell size and development.

Area of Science:

  • Genetics
  • Cell Biology
  • Developmental Biology

Background:

  • Tuberous sclerosis is a human genetic disorder linked to mutations in TSC1 or TSC2 tumor suppressor genes.
  • Previous research suggested Drosophila TSC2 homologs control DNA content, leading to polyploidy and enlarged cells upon loss of function.

Purpose of the Study:

  • To investigate the function of the Drosophila TSC1 gene homolog.
  • To elucidate the relationship between TSC1, TSC2, and insulin signaling pathways in cellular growth regulation.

Main Methods:

  • Isolation and characterization of mutations in the Drosophila TSC1 gene homolog.
  • Analysis of TSC1 and TSC2 complex formation and their role in a common cellular growth pathway.
  • Genetic analysis of TSC gene heterozygosity in rescuing insulin receptor mutants.

Main Results:

  • TSC1 and TSC2 form a complex and function in a common pathway controlling cellular growth.
  • Contrary to previous findings, TSC1 or TSC2 loss-of-function cells remain diploid.
  • Heterozygosity for TSC1 or TSC2 rescues lethality in loss-of-function insulin receptor mutants.
  • TSC genes operate in a parallel pathway converging on the insulin pathway downstream of Akt.

Conclusions:

  • TSC1 and TSC2 are identified as novel negative regulators of insulin signaling.
  • The TSC complex plays a crucial role in controlling cellular growth and is integrated with the insulin pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...